ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AG9. A total of 18 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WHITEBOX ADVISORS LLC | 18,228,000 | $67,928,000 | 2.72% |
| EQUITEC SPECIALISTS, LLC | 2,393,000 | $8,892,000 | 2.30% |
| Nantahala Capital Management | 2,500,000 | $9,319,000 | 1.31% |
| Fore Research & Management, LP | 6,331,000 | $23,555,000 | 1.28% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,570,000 | $42,944,000 | 0.84% |
| DEUTSCHE BANK AG\ | 9,943,000 | $36,944,000 | 0.02% |
| FMR LLC | 6,000,000 | $22,294,000 | 0.00% |
| Allianz Asset Management GmbH | 500,000 | $1,860,000 | 0.00% |
| MANAGED ACCOUNT ADVISORS LLC | 1,000 | $4,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 6,000 | $22,000 | 0.00% |